Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue decline of 18.9% year-on-year for 2025, with a net profit decrease of 34.1%. The revenue for 2025 was 2.453 billion yuan, and the net profit was 1.291 billion yuan. The fourth quarter alone saw a revenue of 588 million yuan, down 9.6%, and a net profit of 198 million yuan, down 46.9% [5] - The forecast for net profit for 2026-2028 is adjusted to 1.515 billion yuan, 1.707 billion yuan, and 1.865 billion yuan respectively, with corresponding EPS of 5.01 yuan, 5.64 yuan, and 6.16 yuan. The current stock price corresponds to a PE of 27.7, 24.6, and 22.5 times for the years 2026-2028 [5] - The company has a rich product matrix and is expanding its international channels, which is expected to drive future growth. The valuation is considered reasonable, hence the "Buy" rating is maintained [5] Financial Summary - In 2025, the company's solution products generated revenue of 1.265 billion yuan (down 27.5%) with a gross margin of 93.1%. Gel products generated 890 million yuan (down 26.8%) with a gross margin of 97.3%. The newly added lyophilized powder injection products generated 208 million yuan, accounting for 8.5% of total revenue [6] - The overall gross margin for 2025 was 92.7% (down 1.9 percentage points), and the net margin was 53.1% (down 11.6 percentage points) due to intensified industry competition [6] - The company's operating expenses for 2025 were 15.8% for sales, 7.4% for management, and 14.7% for R&D, reflecting increases of 6.6 percentage points, 3.3 percentage points, and 4.7 percentage points respectively [6] Product and Channel Development - The product line is expected to grow steadily, with new approvals such as the A-type botulinum toxin "Orange Toxin" in January 2026, creating a one-stop aesthetic solution for facial aesthetics [7] - The company is enhancing its domestic sales channels and has expanded its international presence through the acquisition of REGEN, covering markets in dozens of countries [7]